Telemedicine in Inflammatory Bowel Disease: Opportunities and Approaches

Data de publicació: 01/02/2015

Autors de IIS La Fe

Mariam Aguas Peris

Autor
Raquel Faubel Cava

Autor
Guillermo Bastida Paz

Autor
Bernardo Valdivieso Martínez

Autor
Pilar Nos Mateu

Autor

Autors aliens a IIS La Fe

Del Hoyo J
Bebia P
Barrios A

Grups d'Investigació

Enfermedad Inflamatoria Intestinal

Leader

Pilar Nos Mateu
Unidad Mixta de Investigacion en TICs aplicadas a la reingeniería en procesos sociosanitarios (ERPSS)

Investigador Principal

María Eugenia Gas López

Abstract

This review article summarizes the evidence about telemedicine applications (e.g., telemonitoring, teleconsulting, and tele-education) in the management of patients with inflammatory bowel disease (IBD), and we aim to give an overview of the acceptance and impact of these interventions on health outcomes. Based on the literature search on inflammatory bowel disease, Crohn's disease and ulcerative colitis in combination with e-health, telemedicine, and telemanagement, we selected 58 titles and abstracts published up to June 2014 and searched in PubMed, EMBASE, MEDLINE, Cochrane Database, Web of Science and Conference Proceedings. Titles and abstracts were screened for a set of inclusion criteria: e-health intervention, IBD as the main disease, and a primary study performed. Finally, 16 were included for full reading, data extraction, and critical appraisal of the evaluation. Most studies use telemonitoring (home telemanagement system or web portal) and telecare (real-time telephone and image) as telemedicine applications and assessed the feasibility and acceptance of these systems, adherence to treatment, quality of life, and patient knowledge, particularly in patients with ulcerative colitis. Furthermore, some of these studies evaluated the patients' empowerment, health care costs, and safety of telemonitoring in IBD. In conclusion, the health outcomes of telemedicine applications in IBD suggest that these could be implemented in clinical practice because they are safe and feasible applications that are well accepted by the patient and improve adherence, quality of life, and disease knowledge. Further studies with large sample sizes and complex diseases are needed to confirm these results.

Dades de la publicació

ISSN/ISSNe:: 1078-0998, 1536-4844
Tipus:: Article
Pàgines:: 392-399
DOI:: 10.1097/MIB.0000000000000241
PubMed:: 25437818
Factor d'Impacte:: 2,356 SCImago ℠
Quartil:: Q1 SCImago ℠

Documents

No hi ha documents

Mètriques

Filiacions

Aguas Peris M:: Instituto de Investigación. *Health Research Institute "La Fe University Hospital," Valencia, Spain

†CIBEREHD (Networked Biomedical Research Center for Hepatic and Digestive Diseases), Valencia, Spain

Instituto de Investigación. ‡Department of Gastroenterology, La Fe University and Polytechnic Hospital, Valencia, Spain

§Morales Meseguer Hospital, Murcia, Spain

?Instituto de Aplicaciones de las Tecnologías de la Información y Comunicaciones Avanzadas (ITACA), Politechnic University, Valencia, Spain

Instituto de Investigación. ¶Telemedicine Unit, La Fe University and Politechnic Hospital, Valencia, Spain

and **Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Valencia, Spain